Sign in
WithdrawnNo phase

Laser Treatment of Genito-urinary Syndrome in Women

Key facts

Who runs it
Herning Hospital
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Started
1 Oct 2022
Expected to end
31 Dec 2026
Type of study
Interventional, 8 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Vaginal laser treatment
  • sham
  • laser system
Record updated
16 October 2024
Why it stopped
Hospital terminated treatment with laser

Who can take part

Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • menopause i.e. age more than 50 years and absence of menstruation for twelve months
  • breast cancer
  • endometrial cancer
  • symptoms of vaginal dryness
  • dyspareunia rated as moderate or severe most bothersome symptoms

Who cannot take part

  • use of vaginal moisturizers, lubricants or any other local preparation within the thirty days prior to inclusion
  • previous reconstructive pelvic surgery
  • acute or recurrent urinary tract infections
  • active genital infections i.e. herpes genitalis, candida
  • any serious disease or chronic condition that could interfere with study compliance except from breast and endometrial cancer
  • psychiatric disorders precluding informed consent
  • pelvis organ prolapse stage 2

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Women with genitourinary syndrome of menopause, overactive bladder, with breast or endometrial cancer are randomized to either laser treatment og sham treatment for 3 months. The randomization is stratified for estrogen treatment. The effect is evaluated by questionnaire, histology and microbiology swaps

The 8 groups in the trial

  • Menopausal LaserExisting treatment, for comparison

    20 women with vaginal laser treatment

    Treatment: Vaginal laser treatment and laser system

  • Menopausal shamSham treatment, for comparison

    20 women with probe, no active laser ray

    Treatment: sham

  • breast cancer laserExisting treatment, for comparison

    20 women with breast cancer with vaginal laser treatment

    Treatment: Vaginal laser treatment and laser system

  • breast cancer shamSham treatment, for comparison

    20 women with breast cancer with vaginal probe, no active laser rays

    Treatment: sham

  • endometrial cancer laserExisting treatment, for comparison

    20 women with endometrial cancer with vaginal laser treatment

    Treatment: Vaginal laser treatment and laser system

  • endometrial cancer shamSham treatment, for comparison

    20 women with endometrial cancer with vaginal probe, no active laser rays

    Treatment: sham

  • overactive bladder laserExisting treatment, for comparison

    20 women with overactive bladder with vaginal laser treatment

    Treatment: Vaginal laser treatment and laser system

  • Overactive bladder shamSham treatment, for comparison

    20 women with overactive bladder with vaginal probe, no active laser rays

    Treatment: sham

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Laser Treatment of Genito-urinary Syndrome in Women With Breast and Endometrial Cancer and Menopausal Women
Record updated
16 October 2024